By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Cronus Technologies and Axela today announced a distribution deal to market Axela's instruments in the UK and Ireland.
Laurence Bouet, Innopsys' managing director, said that the firm has placed about 200 InnoScan scanners so far, mainly in Europe and Asia, but expects to expand its installed base by increasing sales in the US this year.
CNN reports that researchers have tied a new variant to opioid addiction risk.
Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.
An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.
In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.